
Approvals & Mergers: Inside Enzyvant with Bill Symonds, Pharm.D.
Business Of Biotech
00:00
The Importance of Complementary Assets in Biopharma
The business of biotech brings those voices forward to help new and emerging bio farmers turn their innovations into clinical realities. The podcast is brought to you in collaboration with CITiva.com backslash emerging biotech. Tune in and subscribe for insights on hiring, regulatory and other need to know topics for biopharma leaders.
Transcript
Play full episode